Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes

Pediatric Diabetes

Volumn 16, Issue 1, 2015, Pages 58-66

  Plener, Paul L ^a   Molz, Esther ^a   Berger, Gabriele ^b   Schober, Edith ^b   Mönkemöller, Kirsten ^c   Denzer, Christian ^a   Goldbeck, Lutz ^a   Holl, Reinhard W ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^c Kinderklinik Amsterdamerstr ^*  (Germany)

Author keywords

Adolescents; Antidepressants; Depression; Metabolic control; Type 1 diabetes

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL; TRICYCLIC ANTIDEPRESSANT AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; DEPRESSION; DIABETIC KETOACIDOSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL CARE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT; CLINICAL TRIAL; COMPLICATION; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; GERMANY; METABOLISM; MULTICENTER STUDY;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; CHILD; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; FEMALE; GERMANY; HUMANS; MALE; YOUNG ADULT;

EID: 84921603971     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12130     Document Type: Article

References (42)

1. Grey M, Whittemore R, Tamborlane W. Depression in type 1 diabetes in children. Natural history and correlates. J Psychosom Res 2002: 53: 907-911.
2. Kovacs M, Goldston D, Obrosky DS, Drash A. Major depressive disorder in youths with IDDM. Diabetes Care 1997: 20: 45-51.
3. Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologica 2011: 54: 2483-2493.
4. Goldston DB, Kelley AE, Reboussin DM et al. Suicidal ideation and behavior and noncompliance with the medical regimen among diabetic adolescents. J Am Acad Child Adolesc Psychiatry 1997: 36: 1528-1536.
5. Shomaker LB, Tanofsky-Kraff M, Young-Hyman D et al. Psychological symptoms and insulin sensitivity in adolescents. Pediatr Diabetes 2010: 11: 417-423.
6. Anderson BJ, Mckay SV. Barriers to glycemic control in youth with type 1 diabetes and type 2 diabetes. Pediatr Diabetes 2011: 12: 197-205.
7. Hood KK, Rausch JR, Dolan LM. Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change. Pediatr Diabetes 2011: 12: 718-723.
8. Le TK Curtisb, Kahle-Worbleski K, Johnston J, Haldane D, Melfi C. Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder. J Med Econ 2011: 14: 440-447.
9. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003: 54: 317-329.
10. Scott KM, Von Korff M, Aangermeyer MC et al. Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. Arch Gen Psychiatry 2011: 68: 838-844.
11. Roy A, Roy M, Goldman D. Childhood trauma and depressive symptoms in type 1 diabetes. J Clin Psychiatry 2011: 72: 1049-1053.
12. Hood KK, Lawrence JM, Anderson A et al. SEARCH for diabetes in youth study group. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care 2012: 35: 2443-2446.
13. Lawrence JM, Standiford DA, Loots B et al. SEARCH for Diabetes in Youth Study. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for diabetes in youth study. Pediatrics 2006: 117: 1348-1358.
14. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
15. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilk 2001: 149: 807-818.
16. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992: 11: 1305-1319.
17. Wolfsdorf J, Craig ME, Dannemann D et al. ISPAD clinical practice consensus guidelines 2006-2007: diabetic ketoacidosis. Pediatr Diabetes 2007: 8: 28-43.
18. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009: 10 (Suppl. 12): 134-145.
19. Rewers A, Chase HP, Mackenzie T et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511-2518.
20. Fritsch M, Rosenbauer J, Schober E, Neu A, Placzek K, Holl RW. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes 2011: 12: 307-312.
21. Rosenbauer A, Dost A, Karges B et al. Improved metabolic control in children and adolescents with type 1 diabetes. Diabetes Care 2012: 35: 80-86.
22. Icks A, Strassburger K, Baechle C et al. Frequency and cost of diabetic ketoacidosis in Germany-study in 12001 paediatric patients. Exp Clin Endocrinol Diabetes 2013: 121: 58-39.
23. Hilliard ME, Herzer M, Dolan LM, Hood KK. Psychological screening in adolescents with type 1 diabetes predicts outcomes one year later. Diabetes Res Clin Pract 2011: 94: 39-44.
24. Garrison MM, Katon WJ, Richardson LP. The impact of psychiatric comorbidities on readmissions for diabetes in youth. Diabetes Care 2005: 28: 2150-2154.
25. Stewart SM, Rao U, Emslie GJ, Klein D, White PC. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pedicatrics 2005: 115: 1315-1319.
26. Zuckerbrot RA Cheungah, Jensen PS, Stein Rek, Laraque D, GLAD-PC Steering Group. Guidelines for adolescents depression in primary care (GLAD-PC): I. Identification, assessment, and initial management. Pedicatrics 2007: 120: e1299-e1312.
27. Ivanova A, Nitka D, Schmitz N. Epidemiology of antidepressant medication use in the Canadian diabetes population. Soc Psychiatry Psychiatr Epiodemiol 2010: 45: 911-919.
28. Hoffmann F, Glaeske G, Petermann F, Bachmann CJ. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data. Pharmacoepidemiol Drug Saf 2012: 21: 972-979.
29. Plener PL, Fegert JM, Koelch MG. The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the "black box" warning. Z Kinder Jugendpsychiatr Psychother 2012: 40: 365-371.
30. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001: 13: 31-41.
31. Knol MK, Derijks HJ, Geerlings MI et al. Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiol Drug Saf 2008: 17: 577-586.
32. Anderson RJ, Gott BM, Sayuk GS, Freedland KE, Lustman PJ. Antidepressant pharmacotherapy in adults with type 2 diabetes. Diabetes Care 2010: 33: 485-489.
33. Rubin RR May, Marrero DG, Peyrot M et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008: 31: 420-426.
34. Rubin RR May, Peyrot M, Marrero DG Pricedw, Barrett-Connor E, Knowler WC, Diabetes Prevention Program Research Group. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcome study. Diabetes Care 2010: 33: 2549-2551.
35. Lewinsohn PM, Solomon A, Seeley J, Zeiss A. Clinical implications of "subtreshold" depressive symptoms. J Abnorm Psychol 2000: 109: 345-351.
36. Briggs-Gowan MJ, Horwitz SM Schwab-Stoneme, Leventhal JM, Leaf PJ. Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry 2000: 39: 841-849.
37. Ndetei DM, Khasakhala LI, Mutiso VN, Mbwayo AW. Recognition of depression in children in general hospital-based paediatric units in Kenya: practice and policy implications. Ann Gen Psychiatr 2009: 8: 25.
38. Butwicka A, Fendler W, Zalepa A et al. Efficacy of metabolic and psychological screening for Mood disorders among children with type 1 diabetes. Diabetes Care 2012: 35: 2133-2139.
39. De Wit M, Snoek FJ. Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web survey. Pediatr Diabetes 2011: 12: 172-176.
40. Delamater AM. Psychological care of children and adolescents with diabetes. Pediatr Diabetes 2009: 10 (Suppl. 12): 175-184.
41. Colton PA, Olmsted MP, Daneman D, Rodin GM. Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes. Pediatr Diabetes 2013: 14: 372-376.
42. Katon WJ, Lin Ehb, Von Korff M et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010: 363: 2611-2620.